Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Neurocognitive Research
KW-6356 is a rare liquid research compound. Each 30ML bottle holds 5MG per mL, or 150MG in total. Labs use it to study the adenosine A2A receptor. A second focus is how this receptor works with the dopamine system. Other topics include motor pathway signaling and CNS receptor selectivity.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkShipping batch 339DR
Open the certificate matched to this shipping batch.
Verified test results
Each batch is analyzed by Chromate, an independent third-party laboratory, before release. Below is the report for lot 339DR, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Peer-reviewed literature
Every reference below is a published, peer-reviewed record, linked to its PubMed entry. Provided for educational reference only - not product claims.
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Liquid research preparation
KW-6356 is a rare liquid research compound. Each 30ML bottle holds 5MG per mL, or 150MG in total. Labs use it to study the adenosine A2A receptor. A second focus is how this receptor works with the dopamine system. Other topics include motor pathway signaling and CNS receptor selectivity.
It is not a common catalog item. We supply it as a finished liquid. Each batch gets an in-house QA check, and our own team ships every order.
| Compound | KW-6356 (also written KW6356) |
|---|---|
| Strength | 5MG/ML |
| Volume | 30ML |
| Total content | 150MG |
| Format | finished liquid |
| Molecular weight | 397.4 g/mol |
KW-6356 is a synthetic small molecule, not a peptide. Its generic name (INN) is sipagladenant. It acts at the A2A receptor in two ways. First, it blocks adenosine from binding. Second, it lowers the receptor's own built-in (constitutive) activity. So its developers call it an A2A antagonist and inverse agonist (Ohno et al., 2023).
In lab binding tests, it bound the human form of this receptor tightly and selectively. It also came off the receptor very slowly (Ohno et al., 2023). Our KW-6356 research guide lists more studies and their sources.
Rare liquids need more care than common capsules or powders. Strength, the carrier liquid, labels, records and storage all matter. Before release, we check each batch for:
Certificates for published lots are in our COA portal.
You should be able to check the standards we describe. Learn more about the outside labs we work with: ILS Labs and Chromate.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
Concentration is the stated amount per mL; total content also depends on the container volume. A per-spray amount requires a verified pump output and must not be inferred from concentration alone. Check each component separately for a blend.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
Both, in its developer's words: Kyowa Kirin describes it as an adenosine A2A receptor antagonist/inverse agonist, meaning it blocks adenosine binding and also inhibits the receptor's constitutive activity. In vitro it bound the human A2A receptor with sub-nanomolar affinity, dissociated very slowly and showed insurmountable antagonism.
They come from the same company, now Kyowa Kirin, and both target the adenosine A2A receptor. Istradefylline is an alkylxanthine that behaved as a surmountable antagonist in vitro, while KW-6356 is a thiazole that showed insurmountable antagonism and inverse agonism; co-crystal structures tied its inverse agonism to contacts with His250 and Trp246. Istradefylline was FDA approved in 2019 as Nourianz.
Yes, as research history. Kyowa Kirin ran two phase 1 studies in healthy Japanese and White volunteers, with randomized, double-blind, placebo-controlled and open-label parts, that measured its pharmacokinetics, and a double-blind, placebo-controlled phase 2 trial in Japan that randomized and treated 168 people with early, untreated Parkinson's disease and measured change in MDS-UPDRS Part III scores over 12 weeks.
No. Drugs@FDA lists no product under KW-6356 or its nonproprietary name, sipagladenant. Kyowa Kirin, which discovered it, announced on 15 July 2022 that it was discontinuing the clinical development program, citing the global regulatory landscape, development hurdles and timelines for potential market entry, and a 2023 review lists it as no longer in development for Parkinson's disease.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy